Zhejiang Langhua Pharmaceutical Co., Ltd, is a comprehensive pharmaceutical company engaged in research and development, production, marketing and sourcing of pharmaceutical products. As the subsidiary of world leading drug discovery CRO company Viva bio-tech holdings, Langhua offers our worldwide partners One-Stop CDMO solution in new drug full life-cycle read morefor small molecule Active Pharmaceutical Ingredients (APIs) and Finished Dosage Form, from pre-clinical to commercial supply. Langhua is the leading manufacturer of Spironolactone, Olanzapine, Antivirus and fluoroquinolones in the world, offers our global customers the high-quality and competitive Generic APIs. [website]

Saltigo, a German CMO and wholly-owned subsidiary of specialty chemicals company LANXESS, specializes in producing ISO intermediates, RSM's, and excipients for the pharmaceutical industry.

With a network of 10 manufacturing facilities and an extensive technology portfolio – including cross metathesis, biocatalysis, fluorination (HF & Halex), and Grignard reactions – we read moreexcel at complex multi-step syntheses involving several challenging chemistries. Coupled with world-class process development labs, backward integration into LANXESS building blocks, and comprehensive support services, Saltigo is your trusted partner throughout every stage of the product lifecycle. [website]

LinkChem Technology Co, founded in 2011, is a comprehensive high-tech enterprise integrating drug R&D and production. The core business covers building blocks, intermediates, API, new material small molecular. LinkChem has partnered with over 4,000 pharmaceutical companies and R&D institutions around the world. Guided by market needs, LinkChem drives read moretechnological development through innovation on the basis of "Science, Rigor, Innovation, Cooperation" development philosophy. LinkChem Technology Co is committed to establishing a professional one-stop CDMO platform for biomedicine. [website]